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Congenital cataract (CC) is a problem worldwide, and 
34% of all CC cases in Denmark are inherited and caused 
by genetic modifications [1]. CC is heterogeneous in terms 
of clinical expression and molecular background, and auto-
somal dominant inheritance is the most common form [1,2]. 
More than 44 genetic loci have been mapped, and a causative 
CC gene has been characterized in 33 of the loci [3]. The 
mutations characterized in association with CC are found in 
several different gene families such as the lens crystallins 
[4,5]; in membrane proteins, such as the gap junction protein 
genes (connexins) [6]; in transcription factors, such as HSF4 
(Gene ID 3299, OMIM  602438) [7] and growth factors [8]; 
and in intermediate filament proteins, such as MIP  (Gene ID 
4284, OMIM 154050) [9].
In 1992, we described an autosomal dominantly inherited 
cataract coined Volkmann cataract (CCV), which segregated 
in ten generations in a large family of 426 persons [10]. The 
CCV cataract is characterized by early debut and progressive, 
central, and zonular cataract with opacities in the embryonic, 
fetal, and juvenile nucleus and around the anterior and poste-
rior Y-suture. CCV is transmitted as a dominant Mendelian 
trait with a penetrance of 0.90. Furthermore, few mutation 
carriers have a hardly recognizable cataract, and 10% have 
normal vision. Mutation carriers who develop pronounced 
cataract during the first or second decade of life need surgery 
[10].
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Purpose: To identify the mutation for Volkmann cataract (CTRCT8) at 1p36.33.
Methods: The genes in the candidate region 1p36.33 were Sanger and parallel deep sequenced, and informative single 
nucleotide polymorphisms (SNPs) were identified for linkage analysis. Expression analysis with reverse transcription 
polymerase chain reaction (RT-PCR) of the candidate gene was performed using RNA from different human tissues. 
Quantitative transcription polymerase chain reaction (qRT-PCR) analysis of the GNB1 gene was performed in affected 
and healthy individuals. Bioinformatic analysis of the linkage regions including the candidate gene was performed.
Results: Linkage analysis of the 1p36.33 CCV locus applying new marker systems obtained with Sanger and deep 
sequencing reduced the candidate locus from 2.1 Mb to 0.389 Mb flanked by the markers STS-22AC and rs549772338 
and resulted in an logarithm of the odds (LOD) score of Z = 21.67. The identified mutation, rs763295804, affects the 
donor splice site in the long non-coding RNA gene RP1–140A9.1 (ENSG00000231050). The gene including splice-site 
junctions is conserved in primates but not in other mammalian genomes, and two alternative transcripts were shown 
with RT–PCR. One of these transcripts represented a lens cell–specific transcript. Meta-analysis of the Cross-Linking-
Immuno-Precipitation sequencing (CLIP-Seq) data suggested the RNA binding protein (RBP) eIF4AIII is an active 
counterpart for RP1–140A9.1, and several miRNA and transcription factors binding sites were predicted in the proximity 
of the mutation. ENCODE DNase I hypersensitivity and histone methylation and acetylation data suggest the genomic 
region may have regulatory functions.
Conclusions: The mutation in RP1–140A9.1 suggests the long non-coding RNA as the candidate cataract gene associated 
with the autosomal dominant inherited congenital cataract from CCV. The mutation has the potential to destroy exon/
intron splicing of both transcripts of RP1–140A9.1. Sanger and massive deep resequencing of the linkage region failed 
to identify alternative candidates suggesting the mutation in RP1–140A9.1 is causative for the CCV phenotype.
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This disease was mapped to a region telomeric to D1S243 
(region 1pter-CCV-D1S243) at 1q36.3 with a logarithm of the 
odds (LOD) score of Zmax = 14.04, θM = 0.025, θF = 0.000, 
and a penetrance of 0.90 [11]. A total of 107 blood samples 
were initially collected in the Volkmann family for linkage 
analysis. One affected person without the disease haplotype 
in the linkage region lowered the LOD score, and the absence 
of informative marker systems in the 1pter region hindered 
further mapping of the CCV locus in the first study. The 
Volkmann CCV locus is the only cataract locus reported 
in the 1pter region, and the nearest cataract locus CTRCT6 
(OMIM 116600) [12-14] 15 Mb proximal to the CCV locus 
was excluded by the linkage analysis (Z = –5) and Sanger 
sequencing of the EPHA2  (Gene ID 1969, OMIM 176946) 
gene.
We report CCV associated with a mutation in a long 
non-coding RNA gene (lncRNA), RP1–140A9.1, with an 
unknown function. The mutation was identified with next-
generation sequencing (NGS) of the linkage region 1pter 
and is predicted to interrupt a donor splice site. The gene 
and the exon/intron boundaries are conserved in the primate 
genomes, and bioinformatics analyses suggest the mutation 
is located in a putative promoter region with several miRNA 
target sites and may function as an “miRNA sponge” or as 
competing endogenous RNA (ceRNA) [15]. Furthermore, 
the mutation interrupts a potential binding site for the RNA 
binding protein eIF4AIII.
METHODS
Clinical data and linkage analysis: The clinical examina-
tion including the pedigree of the multigenerational family 
(107 individuals) and the initial mapping of the CCV locus 
has been published [10,11]. The follow-up analysis included 
eight new individuals; therefore, the final linkage analysis 
comprised 115 family members. The linkage analysis was 
performed using LIPED software [16] with a penetrance of 
p = 0.9 and a frequency of 0.001 for the disease. The study 
protocols adhered to the tenets of the Declaration of Helsinki 
and the ARVO statement on human subjects. The study 
received approval from the Danish National Committee on 
Health Research Ethics in 1990 and 2014 and all participants 
were informed orally and provided written consent.
DNA isolation and sequencing: DNA was extracted from 
ethylenediamine tetra-acetic acid (EDTA) blood using stan-
dard phenol chloroform extraction. Informative sequence-
tagged site (STS) markers and single nucleotide polymor-
phisms (SNPs) used for haplotype construction were found 
with Sanger sequencing of 41 genes telomeric to D1S243 in 
IV:1 and III:11 (Appendix 1) and targeted NGS sequencing 
of the region. Oligonucleotides were designed by Primer3 
[17] and purchased from TAG Copenhagen (Copenhagen, 
Denmark). Chromosome karyotyping and comparative 
genomic hybridization (CGH) analysis were performed 
with standard methods, and copy number variation (CNV) 
analysis was performed using SNP 6.0 arrays (Affymetrix, 
Santa Clara, CA; Appendix 1). PCR was performed using 
standard conditions and the primer pair CCV-mut-F/-R for 
the transcript analysis of RP1–140A9.1 and rs75047691-RNA-
F/-R, B2M_11571/11572 and GAPDH_107/108 for the quanta-
tive reverse transcriptase PCR (qRT-PCR) analysis of GNB1 
(Gene ID 2782, OMIM 139380; Appendix 2). PCR conditions 
included a 5 min melting step at 98 °C followed by 40 cycles 
of 96 °C for 30 s, 65 °C for 30 s, and 72 °C for 30 s followed 
by 72 °C for 5 min. Bidirectional Sanger sequencing (ABI 
Big Dye version 1.1 and ABI3100 DNA Sequencer, Applied 
Biosystems, Foster City, CA) was performed in a minimum of 
two affected individuals. Targeted next-generation sequencing 
(targeted NGS) was performed for index patient IV:3, and 
whole genome sequencing (WGS, BGI Europe, ≤800 bp 
insert normal library with a minimum coverage of 20 reads 
for the CCV linkage region) was performed for individual 
IV:7 (Appendix 1). Briefly, targeted NGS was done using 
20 µg genomic DNA fragmented by sonication to about 300 
bp DNA, blunt ended, followed by adaptor ligation according 
to the manufacturer’s protocol (Paired-End DNA Sample 
Prep kit, Illumina, San Diego, CA). The library was hybrid-
ized to a custom-made NimbleGen Sequence Capture 385 K 
microarray (Roche Sequence Capture Service, Madison, WI) 
designed for the chr1 region 0.5–2.14 Mb according to the 
manufacturer’s recommendations. The captured fragments 
were sequenced using a Genome Analyzer IIx (Illumina) and 
aligned to hg19 using Eland (ABI software package) allowing 
up to two mismatches in the 32 base seed sequence. Indels 
analysis was done by applying the Burrows-Wheeler Aligner 
[18], and inversions where detected by analyzing WGS data 
for clusters of read-pairs  [19] where both reads align in the 
same orientation. The coverage of the region was continuous 
with an average sequencing depth of 40 reads, and exons 
covered by fewer than ten reads were Sanger sequenced.
RNA isolation, cDNA construction, and qPCR: Total RNA 
was extracted from Epstein Barr transformed B-lymphocytes 
[19], whole venous blood was taken from five healthy and 
affected individuals individuals (later frozen) and from 
human eye [20] using an RNeasy mini kit from Qiagen (Cat 
No./ID: 74,104; Hilden, Germany). Human universal refer-
ence RNA was purchased from Agilent (Cat. No. 740,000; 
Santa Clara, CA). PCR expression analysis of a human 
tissue panel of RNA was conducted as described previously 
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[21]. PCR conditions included a 3 min melting step at 95 °C 
followed by 40 cycles of 95 °C for 30 s, 60 °C of 30 s.
Total RNA treated with DNase I from Agilent was used 
for the cDNA synthesis employing Superscript II-RT and 
poly-A priming according to the manufacturer’s protocol 
(Thermo Fisher Scientific, Waltham, MA). cDNA from 
human lens epithelial cells was purchased from ScienCell 
(HLEpiC Cat. No. 6554; Carlsbad, CA). qPCR was performed 
using the Brilliant III Ultra-Fast Sybr qRT-PCR kit following 
the manufacturer’s protocol from AH-Diagnostics (Denmark) 
and included GNB1 (OMIM 139380) and the housekeeping 
genes B2M  (OMIM 109700) and GAPDH (OMIM 138400). 
Data were normalized as described previously [22].
SNP analysis of the NGS data: The targeted NGS and WGS 
data were analyzed for known and novel SNPs (dbSNP 
build142), and SNPs with allele frequencies (AFs) greater 
than 0.01 were excluded. The remaining SNPs were analyzed 
using Sorting Intolerant From Tolerant (SIFT) for predic-
tion of non-synonymous SNPs [23]. SNPs in coding exons, 
untranslated regions (UTRs), and regulatory regions were 
manually curated. Candidate SNPs were genotyped with PCR 
followed by Sanger sequencing for cosegregation with the 
cataract trait in the family.
CLIP-seq and miRNA target site analyses of non-annotated 
cDNA: Cross-Linking-Immuno-Precipitation sequencing 
(CLIP-Seq) data from multiple cell lines was analyzed 
with in-depth in silico meta-analysis [24] applying multiple 
RNA binding protein (RBP) data sets from starBase (star-
Base, release 2.1) [24]. Searching for RBP partners for the 
RP1–140A9.1 gene allows a comprehensive exploration of 
RBP/ncRNA (non-coding RNA) interaction maps from CLIP-
Seq and Degradome-Seq data [24]. The predicted RBP and 
lncRNA interactions in starBase are processed and presented 
as a summary data set representing data from multiple studies 
with different cell lines and RBPs. Only RBPs that intersect 
the CLIP-Seq with RP1–140A9.1 were included. A biologic 
complexity greater than or equal to 2 was selected, and only 
those reaching the threshold were regarded as statistically 
significant [25]. Analysis of the mutation employed a pipeline 
to predict the effect of the mutations on the RNA secondary 
structure and the miRNA target sites in the lncRNA gene 
[26]. The structural effect was predicted using the RNAsnp 
program [27] employing different folding window sizes. 
Potential miRNA target sites were predicted for the genome 
region encoding RP1–140A9.1. TargetScan (v6.1) [28] and 
miRanda (v3.3a) [29] were applied on wild-type and mutant 
DNA sequences with default settings using human mature 
miRNA sequences from miRBase release 19 [30]. Only 
miRNAs with a predicted target site at the mutation position 
were retained if the target site was exclusive for the wild-type 
or the mutant genotype.
RESULTS
Fine mapping of the CCV locus minimized the linkage region: 
DNA Sanger sequencing of the coding exons and targeted 
NGS and WGS of the published CCV locus resulted in a 
series of novel SNPs making refinement of the previously 
published linkage region possible. Using the new marker 
systems in a two-point linkage analysis reduced the CCV 
locus from 2.14 to 0.389 Mb and an LOD score Z = 21.67 
(theta = 0, penetrance = 0.9; Figure 1A,B). Recombination 
events in individuals II:3 and II:5 excluded the region telo-
meric to STS-22AC, and recombination in individual II:4 
excluded the region proximal to rs549772338 (Figure 1A). 
This new linkage region confirmed the affected individual 
II:4 and the monozygotic twins IV:9 and IV:10 as carriers of 
the disease haplotype, which was impossible previously due 
to the lack of marker systems distal to D1S243 (Figure 1A 
and Appendix 1) [11].
DNA sequencing of the CCV linkage region identified a splice 
donor variant: Chromosomal rearrangements, duplications, 
deletions, and inversions in the CCV locus were excluded 
after chromosomal karyotyping and array CGH analysis of 
individual II:4 and CNV analysis of individual V:1 (Appendix 
1). Sanger sequencing of the coding exons of a total of 41 
genes in the 2.14 Mb linkage region in individuals III:11 and 
IV:1 excluded missense, stop gain/loss, frame shift, and splice 
site mutations as causative for the CCV cataract. Targeted 
NGS and WGS of individuals IV:3 and IV:7 confirmed the 
result obtained with Sanger sequencing, and analysis of the 
deep sequencing data excluded large indels or inversions in 
the region.
All SNPs with AFs greater than 0.01 (dbSNP ver142) 
were excluded from the WGS data (Figure 1B) leaving 41 
variations with an AF of less than 0.01 or unknown AFs for 
further analyses. Of these SNPs, 14, mainly indels, were 
excluded that they were in repeated regions, ten SNPs were 
represented in WGS data from six healthy in-house controls, 
and one SNP with an unknown frequency was later shown to 
be common. Segregation analysis of the remaining 16 SNPs 
excluded nine that did not cosegregate with the disease trait, 
leaving five as putative mutation candidates (Appendix 3). 
These candidates represented four SNPs in introns and one in 
an lncRNA gene. All intergenic and intron-located SNPs were 
excluded, and the SNP (rs763295804) in the lncRNA gene 
was chosen for further investigation. The SNP represented a 
G to C transversion (chr1:1,891,852; hg38) in the RP1–140A9.1 
gene (ENSG00000231050.1). RP1–140A9.1 comprises 
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two exons and one intron, and the mutation affected the 
+1 position in the 5′ GT splice consensus sequence of the 
splice donor site. The functional consequence of the G>C 
mutation is unproven but will most likely affect processing 
of the immature RNA transcript by intron skipping and 
result in a full-length un-spliced product. The RP1–140A9.1 
gene is according to Ensembl gene annotation proposed to 
encode an antisense RNA, and the gene and the exon/intron 
boundaries are conserved in primates but not in rodents or 
other mammal genomes (Appendix  4). The mutation tested 
positive for cosegregation in the 115 members of the CCV 
family included in the linkage analysis [11] and was found 
in all affected individuals and absent in all unaffected indi-
viduals including spouses and was not present in 200 healthy 
Danes (AF<0.0025).
Figure 1. Figure shows the methods used to narrow down the location of the linkage region. A: Segregation of the CCV phenotype is shown 
for a small branch of the large multigenerational Volkmann family [10,11]. The fine-mapped CCV linkage region includes eight loci at 1pter, 
and the disease haplotype is shown boxed and marked in red. The haplotypes for individuals I:1 and I:2 are inferred, and the recombination 
events in individuals II:3, II:4, II:5, and IV:8 are shown with an arrow. Symbols: square, male; circle, female; filled symbol, affected indi-
vidual; dot in a symbol, healthy carrier. B: The chromosomal map of 1p36.33–36.32 shows the Volkmann cataract locus found by the initial 
genome-wide linkage analysis [11] together with the regions covered by direct Sanger sequencing of protein coding genes and with targeted 
next-generation sequencing (NGS) and whole genome sequencing (WGS). The key sequence-tagged sites (STSs) and single nucleotides 
(SNPs) are shown for the 2 Mb telomeric chromosome 1 regions together with the Sanger sequenced genes in the linkage region flanked by 
STS-22AC/ rs761317190 and rs549772338. C: The exon/intron gene structure for the lncRNA gene RP1–140A9.1 (1) includes the position of 
the CCV splice site mutation, the PCR primer pair (F1 and R1) positions, and the length and structure of the corresponding PCR amplicons 
(2–4). The CCV mutation is localized distal in exon 1. The cDNA (218 bp) PCR detected (2) from transformed B-leucocytes. The cDNA 324 
bp PCR product detected (3) from two different mixed carcinoma cell preparations and from a lens cDNA library. A 500 bp band (4) from 
gDNA. The alternative splice sites shown in (2,3) are proposed by the NetGene2 predictor. The enhancer-promoter-associated histone mark 
H3K27ac (5) is active in the lncRNA gene RP1–140A9.1. The positions are shown for the four CAGCTG repeats (6) found in the region. The 
CAGCTG palindrome is a putative binding site for hsa-miR-1207-3p (seed sequence CAGCUG) and a binding site for the transcription factor 
AP-4 [35] proposed by TFSEARCH. The palindrome sequence at the exon/intron border is present only in the mutant sequence.
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RNA analysis revealed two RP1–140A9.1 transcripts: The 
RP1–140A9.1 gene is annotated with one RNA transcript 
(ENST00000412228.1). RT–PCR analyses of RNA isolated 
from a panel human tissues revealed the RP1–140A9.1 gene 
was not expressed or expressed at low levels. PCR using the 
primer pair CCV-mut-F/-R and RNA isolated from Epstein 
Barr virus (EBV)–transformed B-leucocytes from a healthy 
control individual revealed a 218 bp PCR fragment. Analysis 
of RNA from cancer cell lines (human universal reference 
RNA), human fetal eye, and human lens epithelial cells 
revealed a 324 bp PCR product (Figure 2). These results 
suggested two different alternative transcripts for the gene. 
PCR using the same PCR primers and genomic DNA resulted 
in a 500 bp PCR fragment; this PCR product was seen in 
RNA samples without DNase I treatment as seen in cDNA 
from lens epithelial cells. According to the company, the 
lens epithelial cell cDNA was synthesized without DNase 
I treated total RNA (personal communication ScienCell). 
Sanger sequencing of the 500 bp PCR confirmed the genomic 
sequence, sequencing of the 218 bp PCR fragment confirmed 
the ENST00000412228.1 transcript using the donor splice site 
5′-AGA CCT CCA G^g tga gga agg-3′ and the acceptor splice 
site ttt cct cca g^G CCT GCA CCA-3′ (genomic sequences in 
lowercase letters), and Sanger sequencing of the 324 bp PCR 
product revealed an alternative transcript using the same 5′ 
donor splice site and a different ctc tcc cca g^C CAG CGC 
CCT-3′ acceptor site (Figure 1C). The donor and the acceptor 
splice sites are supported by NetGene2 predictor [31], and the 
mutation affects both transcripts.
The CCV mutation is not involved in regulation of GNB1 in 
blood: The G>C mutation is located 735 bp upstream in the 
promoter for the GNB1 gene (NM_002074.4). This promoter 
region is associated with histone marks shown by data from 
the ENCODE project (H3K4Me1/H3K4Me3/H3K27Ac 
marks, UCSC browser hg19) [32], and the mutation may inter-
fere with regulation of GNB1. Employing TFSEARCH [33] 
for prediction of transcription factor binding sites revealed 
the wild-type allele of the promoter had the capacity to bind 
the transcription factor YY1 (DeltaE) [34], and the mutant 
allele had the capacity to bind the AP-4 [35] and Cap [36] 
transcription factors (Appendix 5). qRT-PCR expression 
analysis of GNB1 was performed using RNA from full blood 
from a mutation carrier and healthy individuals as RNA from 
affected and healthy lenses was not available (see Methods). 
qRT-PCR revealed that GNB1 was expressed equally in 
carriers and non-carriers in the family (Appendix 6).
The mutation affects primate-specific miRNA seed sequences: 
Bioinformatics analysis of the functional effect of the G>C 
mutation was made for possible changes in the RNA structure 
and miRNA binding. An RNAsnp analysis [27,37] showed 
no statistically significant effect of the mutation (a p value 
of less than 0.1) on the secondary structure of the un-spliced 
lncRNA transcript either using the sense or the antisense 
strand (Appendix 7). The miRNA target site analysis done 
by miRanda [29] and TargetScan [28] predicted 13 miRNA 
target sites exclusively in the wild-type sequence, and three 
miRNA target sites exclusively in the mutant sequence 
(Appendix 8). Both predictors found miRNA binding sites 
for hsa-miR-4254 and hsa-miR-619 in the wild-type sequence 
that were absent in the mutant sequence, and binding sites for 
hsa-miR-1207-3p and hsa-miR-3135b in the mutant sequence 
(Appendix 7). In addition to the miRNA target sites covering 
the mutation, putative binding sites for hsa-miR-1207-3p and 
hsa-miR-4254 were found in the transcripts.
CLIP-seq analysis: eIF4AIII is a potential RNA binding 
protein for RP1–140A9.1: Five RBPs (RNA binding proteins) 
were by CLIP-seq analysis shown to interact in vitro with 
RP1–140A9.1. Furthermore, 42% of all RP1–140A9.1 
CLIP-reads represented eIF4AIII in CLIP-seq experiments 
conducted in HeLa cells [38]. Using a threshold of 2 in 
biocomplexity [39], only eIF4AIII is a qualified candi-
date as a putative binding partner for RP1–140A9.1. We 
further investigated the three eIF4AIII binding sites found 
in RP1–140A9.1; one site representing 85% of the reads 
Figure 2. RT–PCR amplification products from different tissues 
using the primer set CCV-mut-F/-R. Lane 1: Epstein Barr virus–
transformed B-lymphocytes cell cDNA preparations showing the 
218 bp transcripts. Donor splice site: 5′-AGA CCT CCA G^G TGA 
GGA AGG and the acceptor splice site: TTT CCT CCA G^G CTG 
CAC CA-3′. Lane 2: A 500 bp genomic product. Lane 3: Universal 
Human reference RNA (mixed carcinoma) shows the 324 bp 
product. Donor splice site: 5′-AGA CCT CCA G^G TGA GGA 
AGG and acceptor splice site: CTC TCC CCA G^C CAG CGC 
CCT-3′. Lane 4: cDNA from a human fetal eye from DNase-treated 
RNA. A 324 bp product (arrow) is seen. Lane 5: cDNA from human 
lens epithelial cells (HLEpiC cat. No. 6554 lot no. 2531, ScienCell) 
not DNase treated. A genomic DNA (500 bp) and a 324 bp PCR 
product (arrow) are seen from the spliced RP1–140A9.1. Lane 6: 
100 bp ladder.
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corresponded to a region at position chr1:1,891,820–1,891,881 
(hg38) that included the RP1–140A9.1 mutation. The eIF4AIII 
RBP is a general core component of the splicing-dependent 
multiprotein exon junction complex (EJC) [40] deposited at 
splice junctions on mRNAs [41]. Identification of a putative 
eIF4AIII binding site supports that the intron in RP1–140A9.1 
is spliced out, and the G>C mutation may affect the eIF4AIII 
binding.
DISCUSSION
The cataract phenotype found in the Volkmann family 
displays clinical heterogeneity and incomplete penetrance as 
described by Lund et al. [10]. At least three members of the 
family are healthy carriers of the mutation as found for the 
healthy mother III:5 (Appendix 1) and the monozygote twins, 
who, after clinical reexamination, now have normal vision at 
the age of 30 years old (Figure 1, individuals IV:9 and IV:10). 
One of the twins, IV:9, had a mild cataract at the first clinical 
examination [11].
The multipoint LOD score for the CCV locus was 
initially calculated as Z = 14 [11] and could with the use 
of new marker systems be calculated as Z = 21.67 for the 
updated pedigree now comprising 115 individuals. Chromo-
some rearrangements were excluded with karyotyping, array 
CGH, and SNP 6.0 CNV analyses, which suggested a point 
mutation as the most obvious causative mutation for the CCV 
phenotype. Sanger sequencing of all genes in the initial 2.14 
Mb linkage region excluded missense or protein truncating 
mutations, and the result was verified with NGS of the region. 
New DNA variants found with Sanger and next-generation 
deep sequencing refined the linkage analysis of the CCV 
locus and reduced it to a 0.388 Mb region. The new linkage 
region encoded 11 protein coding genes that all were excluded 
with DNA sequencing and an lncRNA gene with a splice-site 
mutation (Figure 1B).
The NGS data discovered a G>C mutation in lncRNA 
RP1–140A9.1. The gene comprises two exons and one intron, 
and the G>C mutation is located at position +1 in the GT 
consensus donor splice site suggesting it causes intron 
splice defects (Appendix 5). The mutation was found in a 
non-repeated genomic DNA region, which supports it as a 
good candidate that all other variants were in the repeated 
region intronic or intergenic and therefore, were excluded 
as candidates. In addition, the gene and the exon intron 
boundary region are conserved in primates but are not present 
in genomes for rodents or other mammals (Appendix 4). The 
oldest affected person in the Volkmann family could be 
traced back ten generations to Germany [10], suggesting the 
mutation is a central European Caucasian variant.
The mutation was not present in 200 healthy Danes or 
in the 1000 Genomes Project, but present in the gnomAD 
browser with a minor allele frequency (MAF) of 0.001335 
for the European non-Finnish population. In the TOPMed 
project, which represents more than 144,000 participants, the 
five rare SNPs in the candidate region (Appendix 3) all have 
an MAF of 0.0008. This suggested to us that these five rare 
alleles that are found in the Volkmann family are in linkage 
disequilibrium in European and American populations and 
represent a founder haplotype of about 0.38 Mb that can be 
found in a population that has European ancestry.
The G>C splice site mutation likely interferes with 
processing of the transcripts of the RP1–140A9.1 gene. The 
most likely consequence of the splice-site mutation is intron 
skipping resulting in a full length unprocessed RNA tran-
script. We have not been able to verify the consequences of 
the mutation, and RNA analysis of lens tissue from affected 
and unaffected individuals has not been available. RT–PCR 
revealed two alternative transcripts of the lncRNA gene. The 
Ensembl transcript ENST00000412228.1 was found in leuco-
cytes, and a longer new transcript was found in the fetal eye, 
lens epithelial cells, and RNA from cancer cell lines (Figure 
1 and Figure 2). Both transcripts use the same acceptor splice 
site and therefore, will be affected by the mutation.
We analyzed possible open reading frames that could be 
translated into a protein for the two alternative transcripts. 
None of these coded for an open reading frame with sequence 
similarity to known proteins in a search of the NCBI protein 
database. The lack of a protein coding open reading frame 
is in line with the idea that RP1–140A9.1 is an lncRNA gene 
that may function as an antisense RNAgene as suggested by 
Ensembl.
Bioinformatics predictions for the RBP binding sites in 
the exon/intron boundary suggested eIF4AIII as a possible 
candidate. The presence of the eIF4AIII binding site supports 
posttranscriptional processing of the immature RNA leading 
to the two alternative transcripts, and the introduction of the 
mutation in the binding site will disturb the processing of 
the RNA.
The low expression of RP1–140A9.1 in a panel of human 
tissues is in accordance with the expression profile in the 
GTEx Portal, where the gene is low or not expressed at all 
(TPM<1) except in the testis (Gtexportal). The low expression 
of RP1–140A9.1 is in line with what has been reported for 
lncRNA genes, and the representation of the gene exclusively 
in primate genomes corresponds to what has been reported 
for other lncRNAs [42].
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qRT-PCR of the expression of GNB1 showed the muta-
tion has no effects on the expression of the gene in blood. 
Although the analysis of RNA isolated from full blood could 
not exclude that the mutation has a regulatory impact on the 
regulation of GNB1 in lens tissue, GNB1 is not an obvious 
candidate as a cataract disease gene, and GNB1 has been 
associated with severe autosomal dominant intellectual 
disability (MRD42, OMIM 616973) [43].
The function of RP1–140A9.1 is unknown, but it is 
tempting to suggest it is involved in the early develop-
ment lens that Volkmann cataract cause opacities seen in 
the embryonic, fetal, and juvenile nucleus of the lens [10]. 
Incorrect nuclear processing of pre-mRNA splicing or false 
miRNA binding capacities can, in general, have a strong 
impact on downstream functions in the cell [44], and the CCV 
mutation may disturb miRNA binding. For instance, it is a 
fourth target site for hsa-miR-1207-3p predicted in the mutant 
allele of the gene that may then serve as a miRNA sponge for 
hsa-miR-1207-3p.
We considered whether the miRNAs found to interact 
with the lncRNA genes are expressed in the lens or cataract. 
We searched PubMed and GEO, but did not find any direct 
literature match for these miRNAs or data sets for human lens 
and cataract. However, Wu et al. [44] examined miR-1207 in 
the lens and cataract and found that the miR-1207-5p variant 
in transparent lens samples is more expressed compared to 
cataractous samples. Lens-specific regulation for lncRNAs 
and miRNAs is well documented in studies of mouse lenses 
[45,46] and in humans in healthy as well as cataractous lenses 
[47,48]. Results have shown that changes in the concentration 
of different lens miRNAs play a crucial role in the develop-
ment of age-related cataract [49-55], and it is plausible that 
the identified mutation not only is involved in the CCV 
phenotype but also contributes to the development of age-
related cataract. This can explain the relative high AF, and the 
CCV phenotype is a result of more a more complex genetic 
background. Thus, the present results complement what is 
described in the literature.
In conclusion, we sequenced all genes in the candidate 
region for the dominant congenital form of cataracts previ-
ously described in 1995 [10,11] without finding any causative 
pathogenic mutation. Reanalysis of the linkage region using 
new markers reduced the region to 0.389 Mb, and WGS 
and targeted NGS identified a splice-site mutation in the 
lncRNA gene RP1–140A9.1. The mutation segregated with 
the CCV trait in the family and might represent the first 
example of a point mutation in an lncRNA causative for an 
autosomal dominant inherited congenital cataract. Future 
characterization of the RP1–140A9.1 lncRNA gene will hope-
fully elucidate the pathogenesis of Volkmann cataract.
APPENDIX 1.
Selected sub-pedigree for the Volkmann family modified 
from Eiberg et al. [1]. The key persons II:4 and III:8 show 
recombination events (shown by an arrow) that delimit the 
linkage region. Note that the disease haplotype in II:4 is 
telomeric to D1S243 and individuals III:5 and IV:10 are unaf-
fected carriers. One of the twins (IV:9) had a mild cataract at 
age 16, but after reexamination at age 30 had normal vision. 
Individual III:3 had vision problems, but no cataract at the 
time of examination. Inferred haplotypes are shown in italics, 
and the disease haplotype is boxed. The extended pedigree for 
the 426 members large family can be found in [1]. The filled 
symbols represent cataractous affected individuals, squares 
are males and circles are females. III:11 and IV:1 (marked 
S) were Sanger sequenced for 44 genes in the region 1pter-
D1S243, IV:3 (marked T) was target-NGS and IV:7 (marked 
WGS) was whole genome sequenced. 1.  Eiberg H, Lund 
AM, Warburg M, Rosenberg T. Assignment of congenital 
cataract Volkmann type (CCV) to chromosome 1p36. Hum 
Genet 1995; 96: 33-8.  To access the data, click or select the 
words “Appendix 1.”
APPENDIX 2. PCR-PRIMERS.
To access the data, click or select the words “Appendix 2.”
APPENDIX 3. MAF VALUES FOR IDENTIFIED SNPS.
a MAF data is for the non-Finnish Europeans population, 
gnomAD browser. b MAF data is for the American popula-
tion, TOPMed. The American population is very heterog-
enous, and TOPMed. represent a cohort of >144k participants 
representing 40% European ancestry, 32% African, 16% 
Hispanic/Latino, 10% Asian etc. (https://www.nhlbiwgs.
org/). To access the data, click or select the words “Appendix 
3.”
APPENDIX 4. THE GENOMIC REGION AROUND 
THE SPLICE SITE MUTATION IS CONSERVED 
IN 8 PRIMATE GENOMES AND LESS OR NOT 
CONSERVED IN OTHER MAMMALS.
No alignments for: Mouse, Chicken, Marmoset, Tarsier, 
Elephant, Hedgehog, Dolphin. To access the data, click or 
select the words “Appendix 4.”
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APPENDIX 5.
Transcription factor binding site analysis (TFSEARCH, I. 
Ovcharenko unpublished data) discovered the recognition site 
CCTCACCTGG for YY1 (previously named DeltaE) at the 
minus strand. The mutant allele sequence does not match the 
YY1 recognition site but recognition sites for the transcrip-
tion factors AP-4 and Cap. To access the data, click or select 
the words “Appendix 5.”
APPENDIX 6.
qPCR of GNB1 using cDNA made from RNA isolated from 
fetal eye, and whole blood from five healthy individuals and 
five heterozygote mutant carriers. To access the data, click or 
select the words “Appendix 6.”
APPENDIX 7. RNA BINDING PROTEIN CLIP-SEQ 
DATA
RNA binding protein (RBP) CLIP-Seq data subtracted and 
filtered using starBase V2.0. RP1-140A9.1 and the protein 
partners are mapped. Column 1 shows the name of the RBP 
identified; column 2 shows the number of identified target 
sites; column 3 shows the number of individual experiments 
where an RNA–RBP interaction has been observed. Last 
column shows the read count from CLIP-Seq experiments 
where a given RBP is interacting with RP1-140A9.1. To 
access the data, click or select the words “Appendix 7.”
APPENDIX 8. 
Results of miRNA target prediction. The genomic region 
around the RP1-140A9.1 SNP (chr1: 1,891,852 G/C, hg38) 
showing the following tracks from top to bottom: “miRNA 
target predictions by TargetScan” shows miRNA target 
(miRT) sites as predicted by TargetScan [1]. Note that 
TargetScan requires an exact complement match to the seed 
sequence (only the seed sequence is marked). The set of 
miRNAs is limited to those were the mutation is predicted 
to create or destroy a binding site by either TargetScan or 
miRanda. For the predictions that overlap the mutation 
position, it is indicated whether the binding site is specific 
to wild-type “(WT)” or mutant “(MUT)”. Additional target 
sites for those miRNAs predicted along the transcript are also 
shown. Different miRNAs are highlighted with individual 
colors and labeled with miRT-XXX which refers to predicted 
target site for hsa-miR-XXX. “miRNA target predictions 
by miRanda” same details as above but for miRanda [2] 
predictions. “Repeat region” displays the location of the 
self-complementary “CAGCTG” repeats in the lncRNA tran-
script. The repeats that are common in wild-type and mutant 
sequence are shown in dark blue; the new repeat formed by 
the mutation is highlighted in light blue color. “Mutation” 
indicates the position of the G to C mutation in the lncRNA 
gene.“Ensembl Gene Predictions” shows Gencode v24, tran-
script of RP1-140A9.1. “cDNA_1: Found in B-lymphocyte 
cDNA in this study (Figure 2 lane 1), cDNA_2: Found in 
universal RNA, fetal eye and lens cDNA in this study /Figure 
2 lane 3,4 and 5). 1.  TargetScan software for prediction of 
microRNA targets: http://www.targetscan.org/ 2.  Enright AJ, 
John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA 
targets in Drosophila. Genome Biol 2003; 5:R1.1-R14. To 
access the data, click or select the words “Appendix 8.”
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